İdil Rana User’s Post

We have changed our clinical practice - based on new evidence on prevention of postoperative thromboembolism in gynecologic cancer patients treated by minimal invasive surgery (MIS). In the paper by dr Algirdas Markauskas et al we report data from two periodes with different approaches to symptomatic thromboembolic prophylaxis. From January 2015 to September 2021 1856 patients were operated by minimal invasive surgery on suspicion of gynecologic cancer. They had Low Molecule Weight Heparin (LMWH) and compression stocking only during hospitalization. From September 2021 to December 2022 369 patients were treated by 28 days of LMWH prophylaxis according to national guidelines. We found a very low incidence of symptomatic thromboembolic events in both groups (0.2 and 0.3%) without significant difference. Based on these data we have changed our praxis to LMWH administration only during hospital stay for patients operated by MIS. If you want to read more: https://lnkd.in/d6bFN3i4 Thanks to co-authors Algirdas Markauskas, Gudrun Neumann, Jan Blaakær, Koen Traen, Chunsen Wu. #gynækologiskobstetriskforskningsenhed #odenseuniversitetshospital

If you feel a lump during a self-breast exam or get a call that something was spotted on your latest mammogram, your first thought may be, ‘It’s cancer.’ Yes, breast cancer is one of the leading cancer diagnoses in women. But there’s no need for immediate panic. You could have a benign breast condition that is not life-threatening and is not cancer. Generally speaking, benign breast disease is a group of conditions that involve breast changes that are not malignant. These changes can be found on imaging, felt during self-breast exams or discovered following breast discomfort. Benign breast disease is very common. In fact, the team at Telfair Breast Surgery at St. Joseph’s/Candler sees more benign breast conditions than cancer, says Candace Walton, nurse practitioner at Telfair Breast Surgery. “Normally, it starts with imaging, Sometimes it does start with generalized breast pain or they feel a mass,” Walton says. “A lot of patients may have their first mammogram that shows something in their breast that’s been there for a long time, and they just didn’t know it. It gets flagged, such as a cyst, but a large majority of them are benign cysts.” Walton lists some of the more common conditions of benign breast disease: https://lnkd.in/e5BS2MMV #benignbreastdisease #breasthealth #mammograms #mammogram #mammography #nurse #nursepractitioner #nursesoflinkedin #nurses #breastcancer #breastcancerawareness #breastselfexam

What are the needs of patients with thyroid cancer before undergoing surgery? A study conducted interviews with patients with papillary thyroid cancer before their surgery during their preoperative surgical consultation. The research has shown that the central needs of patients are: 📍 Strong patient-surgeon relationship characterized by informational and emotional support, and respect for the patient as a person. 📍 Detailed information about the disease and treatment: treatment would be personalized and aspects of their daily lives would be taken into account. 📍 Enough time to ask questions, with thoughtful answers that are tailored to their specific case. 📍 Empathy and validation of patients' experience with cancer. In particular, patients wanted surgeons to address their fears and anxieties. 📍 Patients also value the surgeons' ability to look beyond their illness and recognize them as unique individuals in terms of their occupation, psychosocial state, and other individual characteristics. Remember: 🔹 Patients rely on the surgeon to provide adequate informational and emotional support and respect them as individuals. This helps patients feel reassured and prepared for treatment. 🔹If patients are well-informed, this will result in better compliance and therefore, better outcomes in terms of quality of life for patients. Pitt SC, Wendt E, Saucke MC, et al. A Qualitative Analysis of the Preoperative Needs of Patients With Papillary Thyroid Cancer. J Surg Res. 2019. #thyroid #cancer #ThyroidCancerAwarenessMonth #patientsfirst #endocrinology

Ekatrasetu Webinar: Pediatric Renal Tumors- Surgical aspects

Less than a week to go until BAUS!   We’re looking forward to a packed three days of all things urology, including what looks set to be right up our street – Tuesday morning’s medac-sponsored symposium on “Are we getting intravesical treatment right in NMIBC?” An international panel led by Prof Param Mariappan (Edinburgh Bladder Cancer Surgery) will be discussing a range of topics, including real-world outcomes in the NHS, the ideal NHS pathway for high-risk NMIBC, and sub-stratification and selecting the right intravesical treatment.   NB medac mitomycin C will be used in the newly announced HIVEC®-HEAT trial in the UK, heated and recirculated via the Combat BRS (Bladder Recirculation System). It will be instilled at double the concentration (1 mg/mL) of standard HIVEC® practice (0.5 mg/mL), with participants additionally receiving up to 15 HIVEC® treatments over one year – which is more than many patients receive out of trial in UK centres.   So see you at BAUS, Monday June 24 to Wednesday June 26 – and if you’ve got any questions about HIVEC®-HEAT, we’ll be very happy to answer them.   #medicalinnovation #BAUS24 #bladdercancer #HIVEC #HIVECHEAT #CombatMedical

Less than a week to go until BAUS!   We’re looking forward to a packed three days of all things urology, including what looks set to be right up our street – Tuesday morning’s medac-sponsored symposium on “Are we getting intravesical treatment right in NMIBC?” An international panel led by Prof Param Mariappan (Edinburgh Bladder Cancer Surgery) will be discussing a range of topics, including real-world outcomes in the NHS, the ideal NHS pathway for high-risk NMIBC, and sub-stratification and selecting the right intravesical treatment.   NB medac mitomycin C will be used in the newly announced HIVEC®-HEAT trial in the UK, heated and recirculated via the Combat BRS (Bladder Recirculation System). It will be instilled at double the concentration (1 mg/mL) of standard HIVEC® practice (0.5 mg/mL), with participants additionally receiving up to 15 HIVEC® treatments over one year – which is more than many patients receive out of trial in UK centres.   So see you at BAUS, Monday June 24 to Wednesday June 26 – and if you’ve got any questions about HIVEC®-HEAT, we’ll be very happy to answer them.   #medicalinnovation #BAUS24 #bladdercancer #HIVEC #HIVECHEAT #CombatMedical

**Understanding Parathyroid Adenoma and Its Hidden Dangers** A 65-year-old woman diagnosed with left breast cancer (cT2N0M0) underwent a preoperative CT scan, which revealed a suspicious lesion near her thyroid. Further tests showed elevated calcium levels (13.7 mg/dL) and a high parathyroid hormone (PTH) level of 560 pg/mL, leading to a diagnosis of parathyroid adenoma – a benign tumor causing primary hyperparathyroidism. Even though she was asymptomatic, this condition can lead to serious complications like kidney stones, bone fractures, and pancreatitis. In fact, her CT scan revealed asymptomatic bilateral renal stones. She successfully underwent surgery to remove the parathyroid adenoma during her breast cancer surgery. Post-op, her PTH levels dropped to normal (11.2 pg/mL), and she is now recovering well. This case underscores the importance of early detection and treatment of parathyroid adenoma to prevent the silent but serious complications of hyperparathyroidism. **Key Points to Remember:** - Elevated calcium and PTH levels can indicate parathyroid adenoma. - Timely surgery can prevent complications like kidney stones and bone damage. - Even asymptomatic patients are at risk for long-term complications. If you or someone you know has elevated calcium or PTH levels, consult your healthcare provider for further evaluation. **Dr. Lala Robin MBBS, MS (General Surgery), DrNB (Surgical Oncology)** [Consult Dr. Lala Robin on iCliniq] https://lnkd.in/gePmPcNB #ParathyroidAdenoma #Hyperparathyroidism #KidneyStones #BoneHealth #BreastCancerAwareness #SurgicalOncology #ThyroidHealth #CalciumLevels #PreventComplications #HealthAwareness

https://lnkd.in/g9-dUH6e Article title: Surgically curable Pancreas Enigma: Solid Pseudopapillary Tumor. Report of a case and literature review   Author(s): Kurşat Rahmi Serin; Muharrem Oner; Nadir Adnan Hacım   Journal: Archives of Clinical Gastroenterology   Journal ISSN: 2455-2283 Abstract   Solid pseudopapillary tumor (SPT) is a rare pancreatic neoplasm, classified as low-grade malignant tumor by the World Health Organization in 2000. Surgical treatment usually provide curative intent. Here in we report a 30 years-old woman whom had been operated upon possible benign pancreatic head mass diagnosed histopathologically as solid pseudopapillary tumor. And we aimed to review the literature on the basis of the case. In conclusion, solid pseudopapillary tumors are slow-growing tumors, with unpredictable potential for malignancy. Aggressive surgery yields favorable results even in the presence of vascular invasion and metastatic disease. #SolidPseudopapillaryTumor #Pancreas #Surgery #InflammatoryBowelDisease #FunctionalGIDisorders #GastrointestinalAndLiverDisease #DigestiveOncology #GastrointestinalSurgery #PediatricGastroenterology #ColorectalCancer #PancreaticCancer #HepatocellularCarcinoma #GastrointestinalBleeding #Endoscopy #Peertechz #PeertechzPublications #SurgicalGastroenterology #StomachUlcers #VirtualColonoscopy #GastricUlceration #RouxenYGastricBypass #GastricAcidSecretion #GastricMucosa #GastricUlcerHealing #GastricCardiaCancer #ReproductiveEndocrinology #EndocrineDisorders #Hepatology #AlimentaryCanal #PancreasCancer

Transcatheter aortic valve replacement (TAVR) can be performed safely in adults with congenital heart disease (CHD) if done by a multidisciplinary team of specialists at a high-volume center, so concludes a Cleveland Clinic case series. TAVR can be an effective intervention in CHD in select clinical scenarios, proving both feasible & safe with good short-term outcomes. In high surgical risk, it can be used as a bridge to recovery, future surgery, transplantation, or palliation. Joanna Ghobrial Tara Karamlou Grant Reed https://lnkd.in/gMXUfMdj

New paper !!!! 🤓📚👨🔬👨⚕️⚕️ https://lnkd.in/egpmmyj4 The Surgical Prehabilitation Multimodal Oncology (SUPREMO) retrospective cohort study Preoperative immunonutrition and postoperative outcomes in patients with cancer undergoing major abdominal surgery: retrospective cohort study A total of 620 patients were included, with 49% receiving a complete preoperative immunonutrition regimen. Bivariate analysis indicated that complete regimen administration was associated with lower intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and vasopressor support requirements (p = 0.005, p = 0.019, and p = 0.032, respectively). The logistic regression model showed a significant reduction in in-hospital infectious complications (odds ratio 0.54, 95% confidence interval 0.31–0.98; p = 0.044). Administering a complete preoperative immunonutrition regimen may be associated with reduced infectious complications, ICU and IMV requirements, and vasopressor support use. #surgeon #cancer #nutritionandcancer #neoplasm #phdstudentlife📚 #team #nutritionalsupport